2-(m-Tolyl)thiazole-4-carbaldehyde

Catalog No.: 
ACCIKL320
CAS No.: 
92422-79-2
Molecular Formula: 
C11H9NOS
Molecular Weight: 
203.27
2-(m-Tolyl)thiazole-4-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$116.00In stockInquiry
250mg95%$198.00In stockInquiry
1g95%$652.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(m-Tolyl)thiazole-4-carbaldehyde
IUPAC Name2-(m-tolyl)thiazole-4-carbaldehyde
MDL No.MFCD06738367
Molecular FormulaC11H9NOS
Molecular Weight203.27
SMILESO=CC1=CSC(C2=CC=CC(C)=C2)=N1
InChI KeyFRSDKJVLVWGYEI-UHFFFAOYSA-N
Synonym2-M-TOLYL-THIAZOLE-4-CARBALDEHYDE;AKOS ISYA01038;2-(3-Methylphenyl)-1,3-thiazole-4-carbaldehyde;2-(3-Methylphenyl)-4-thiazolecarboxaldehyde;2-(M-tolyl)thiazole-4-carbaldehyde - [T9222]
CAS No.92422-79-2
PubChem CID14023573

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACCIKL320 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUNQ805 route compound structure diagram
    ACEUNQ80517933-03-8In Stock
  2. Plus
  3. ACILAM624 route compound structure diagram
    ACILAM6245198-80-1In Stock
  4. Then
  5. ACCIKL320 route product structure diagram
    ACCIKL32092422-79-2In Stock
Inquiry

2. ACCIKL320 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCIKL320 route product structure diagram
    ACCIKL32092422-79-2In Stock
Inquiry

3. ACCIKL320 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCIKL320 route product structure diagram
    ACCIKL32092422-79-2In Stock
Inquiry

Comments (0)